Article ID Journal Published Year Pages File Type
9016465 Progress in Neuro-Psychopharmacology and Biological Psychiatry 2005 8 Pages PDF
Abstract
Findings suggest that a definition of mixed depression requiring 3 or more intra-MDE hypomanic symptoms may be a useful clinical marker for predicting the diagnosis of BP-II. Presence of mixed depression should lead to skillful probing for history of hypomania, which would probably reduce the BP-II misdiagnosed as MDD. Findings may also impact treatment of BP-II, as intra-MDE hypomanic symptoms may become more severe by antidepressants alone, and mood stabilising agents may be required before (or concurrently with) antidepressants.
Related Topics
Life Sciences Neuroscience Biological Psychiatry
Authors
,